DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Melcher C, Schochter F, Albrecht S et al.
DETECT IV – a multicenter, single arm, phase II study evaluating the efficacy of Everolimus in combination with endocrine therapy in patients with HER2-negative, hormone-receptor positive metastatic breast cancer and exclusively HER2-negative circulating tumor cells (CTCs).

Oncol Res Treat 2014;
37: 29-29

Download Bibliographical Data

Search in: